Morgan Stanley
CPXX

Morgan Stanley’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Morgan Stanley’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-607,639
Closed -$18.3M – 6711
2016
Q2 		$18.3M Buy
607,639
+592,972
+4,043% +$12M 0.01% 1487
2016
Q1 		$162K Buy
14,667
+14,211
+3,116% +$46.6K ﹤0.01% 5093
2015
Q4 		$1K Hold
456
– – ﹤0.01% 6614
2015
Q3 		$1K Buy
456
+398
+686% +$883 ﹤0.01% 6568
2015
Q2 		$0 Buy
58
+1
+2% +$2 ﹤0.01% 6886
2015
Q1 		$0 Hold
57
– – ﹤0.01% 6783
2014
Q4 		$0 Buy
57
+13
+30% +$27 ﹤0.01% 6796
2014
Q3 		$0 Hold
44
– – ﹤0.01% 6771
2014
Q2 		$0 Hold
44
– – ﹤0.01% 6694
2014
Q1 		$0 Buy
+44
New +$149 ﹤0.01% 6634

Morgan Stanley's CPXX Position: Q3 2016 in Review

Morgan Stanley sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 607,639 shares — an estimated $18.3M sold.

Morgan Stanley first reported a position in CPXX in Q1 2014 and held it in 10 quarters. The position peaked at $18.3M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Morgan Stanley reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Morgan Stanley sold 607,639 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $18.3M.
  • Morgan Stanley first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q1 2014 and held it in 10 quarters.
  • Morgan Stanley's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $18.3M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Morgan Stanley's 13F filing for Q3 2016, filed 10 Nov 2016.